Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Merle Leffers"'
Autor:
Jannik Sonnenberg, Dennis Schwarz, Sina MM. Lagache, Lucia Schnack, Helena Körner, Merle Leffers, Hannah Hardege, Yuanyuan Liu, Holger Reinecke, Hannes M. Findeisen, Yahya Sohrabi
Publikováno v:
STAR Protocols, Vol 5, Iss 1, Pp 102776- (2024)
Summary: Non-immune cells, like innate immune cells, can develop a memory-like phenotype in response to priming with microbial compounds or certain metabolites, which enables an enhanced response to a secondary unspecific stimulus. This paper describ
Externí odkaz:
https://doaj.org/article/94f24c6f625d4a30b353545d8b868f33
Publikováno v:
Journal of Cellular and Molecular Medicine
Type 2 diabetes mellitus (T2DM) leads to monocyte dysfunction associated with atherogenesis and defective arteriogenesis. Transforming growth factor (TGF)‐β1, placenta growth factor (PlGF)‐1 and vascular endothelial growth factor (VEGF)A play im
Autor:
Johannes Waltenberger, Evangelia Pardali, Lena-Maria Makowski, Andreas Borgscheiper, Merle Leffers
Publikováno v:
Journal of Cellular and Molecular Medicine
Type 2 diabetes mellitus (T2DM) is a cardiovascular risk factor which leads to atherosclerosis, an inflammatory disease characterized by the infiltration of mononuclear cells in the vessel. Bone morphogenetic protein (BMP)‐2 is a cytokine which has
Autor:
Gale W. Newman, Crystal C. Lipsey, Joy Milner, Johannes Waltenberger, Danielle Daley-Brown, Ruben R. Gonzalez-Perez, Viola Lanier, Leonard M. Anderson, Merle Leffers, Corey Gillespie, Nia Webb
Publikováno v:
The international journal of biochemistrycell biology. 79
Leptin increases vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR-2), and Notch expression in cancer cells, and transphosphorylates VEGFR-2 in endothelial cells. However, the mechanisms involved in leptin's actions in endothelial cel
Autor:
Muna Elhassey, Corey Gillespie, Johannes Waltenberger, Merle Leffers, Ruben R. Gonzalez-Perez, Viola Lanier
Publikováno v:
Cancer Research. 73:377-377
We have previously shown that leptin is a pro-survival factor for breast cancer (BC) cells that reduces the effects of chemotherapeutics. We have also found that leptin is a pro-angiogenic, pro-inflammatory and mitogenic factor that induces the expre
Autor:
Semo, Dilvin1 (AUTHOR), Obergassel, Julius1 (AUTHOR), Dorenkamp, Marc1 (AUTHOR), Hemling, Pia1 (AUTHOR), Strutz, Jasmin2 (AUTHOR), Hiden, Ursula2 (AUTHOR), Müller, Nicolle3 (AUTHOR), Müller, Ulrich Alfons3 (AUTHOR), Zulfikar, Sajan Ahmad4 (AUTHOR), Godfrey, Rinesh1,5 (AUTHOR) rine.godfrey@gmail.com, Waltenberger, Johannes5,6,7 (AUTHOR) rine.godfrey@gmail.com
Publikováno v:
Journal of Clinical Medicine. Feb2023, Vol. 12 Issue 4, p1356. 18p.
Autor:
Dorenkamp, Marc1 (AUTHOR), Nasiry, Madina1 (AUTHOR), Semo, Dilvin1 (AUTHOR), Koch, Sybille1 (AUTHOR), Löffler, Ivonne2 (AUTHOR), Wolf, Gunter2 (AUTHOR), Reinecke, Holger1 (AUTHOR), Godfrey, Rinesh1 (AUTHOR) rine.godfrey@gmail.com
Publikováno v:
Cells (2073-4409). Feb2023, Vol. 12 Issue 3, p513. 19p.
Publikováno v:
Journal of Cellular & Molecular Medicine; Jun2021, Vol. 25 Issue 11, p5316-5325, 10p
Autor:
Pardali, Evangelia, Makowski, Lena‐Maria, Leffers, Merle, Borgscheiper, Andreas, Waltenberger, Johannes
Publikováno v:
Journal of Cellular & Molecular Medicine; Nov2018, Vol. 22 Issue 11, p5429-5438, 10p